|
Market Cap (5-Jun) $55,535,856 (1,270th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 227,504 |
Shortsold (18-Aug) 146,107 (0.01%) (520th) |
|
52w High $0.045 |
52w Low $0.040 |
P/E - |
EPS 0.03 |
DNA released this announcement to the ASX on 26 February 2021, 13:33. The announcement is not marked as price sensitive, and is 16 page(s) in length and 868.85kb in size.
You can view all announcements from DNA and see how they appear on a price chart on the announcements page.
At the date of this announcement, DNA was 0.012% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It remains ranked 520th as of the latest reported data (18 August 2025).
| Other Recent Announcements from DNA | |
|---|---|
| Quarterly Activities Report | 28 April 2023, 16:17 |
| Appendix 4C Cash Flow Report | 28 April 2023, 16:15 |
| 1H FY23 Results Summary | 1 March 2023, 8:45 |
| 1H FY21 Investor Presentation | 26 February 2021, 13:33 |
| 1H FY21 Results Summary | 26 February 2021, 13:25 |
| Appendix 4D and Half Year Financial Report | 26 February 2021, 13:14 |
| 1H FY21 Results Investor Briefing | 18 February 2021, 14:37 |
You must be logged in to post a reply.
Donaco International 